Table 1.

Patient characteristics

	All	New-onset GCA	Established GCA
Gender
Female	22	5	17
Male	13	4	9
Mean age, years	71	72	65
Disease duration, mean in years	2.5 (range 0–4)	< 2 months	2.9 (range 0–8)
Disease onset
Newly diagnosed	9
Established disease	26
Visual manifestations	5	0	5
Jaw claudication	1	1	0
Arm claudication	3	1	2
Patients having temporal artery biopsy (TAB)	23	2	21
TAB positive	15	1	14
CRP (range) g/L	7.5 (1–200)	24 (4–200)	4 (1–57)
Corticosteroid dose (range) mg/day	5 (0–60)	60 (20–60)	5 (0–25)
Steroid sparing medications
Methotrexate	4	0	4
Leflunomide	2	0	2
Etanercept	1	0	1

GCA giant cell arteritis, TAB temporal artery biopsy, CRP C-reactive protein